Aquatic Capital Management’s Revolution Medicines RVMD Stock Holding History

Aquatic Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-33,537	Closed	-$2.67M	–	1751
2025 Q4	$2.67M	Sell	33,537 -13,028	-28%	-$854K	0.08%	308
2025 Q3	$2.17M	Sell	46,565 -19,095	-29%	-$748K	0.04%	464
2025 Q2	$2.42M	Buy	65,660 +20,905	+47%	+$803K	0.05%	426
2025 Q1	$1.58M	Sell	44,755 -68,650	-61%	-$2.79M	0.04%	475
2024 Q4	$4.96M	Buy	113,405 +78,605	+226%	+$3.97M	0.13%	199
2024 Q3	$1.58M	Buy	34,800 +34,600	+17,300%	+$1.51M	0.04%	414
2024 Q2	$7.76K	Buy	+200	New	+$7.47K	﹤0.01%	1134

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aquatic Capital Management's RVMD Position: Q1 2026 in Review

Aquatic Capital Management sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 33,537 shares — an estimated $2.67M sold.

Aquatic Capital Management first reported a position in RVMD in Q2 2024 and held it in 7 quarters. The position peaked at $4.96M in Q4 2024. 514 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Aquatic Capital Management reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
Aquatic Capital Management sold 33,537 Revolution Medicines shares in Q1 2026, an estimated $2.67M.
Aquatic Capital Management first reported a position in Revolution Medicines in Q2 2024 and held it in 7 quarters.
Aquatic Capital Management's Revolution Medicines position peaked at $4.96M in Q4 2024.
514 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.